3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase EARLY_PHASE1
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
11
Neoplasm Metastasis
8
Prostatic Neoplasms
6
Triple Negative Breast Neoplasms
5
Multiple Myeloma
5
Lymphoma, Mantle-Cell
5
Lymphoma
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
4
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Fallopian Tube Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Liposarcoma
2
Glioma
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Renal Cell
2
Interventions
pembrolizumab
3
fludarabine
3
Cyclophosphamide
3
Ipilimumab
2
smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic
1
sargramostim
1
reolysin
1
poly ICLC
1
peginterferon alfa-2a
1
osimertinib
1
gusacitinib
1
fludarabine phosphate
1
eprenetapopt
1
epacadostat
1
dabrafenib
1
cobimetinib
1
cemiplimab
1
Vorinostat
1
Temozolomide
1
Radiotherapy
1
Radiation
1
Poly I-C
1
Nivolumab
1
Monatide (IMS 3015)
1
Methods
1
MAPRE1 protein, human
1
Interleukin-2
1
Interleukin-15
1
Interleukin-12
1
IT-101
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Skin Neoplasms
×
Biopsy
×
Clear all
NCT00715793
2017-10-03
UPCI-07-008
University of Pittsburgh
Phase 1/2
Completed
39 enrolled
12 charts